Interaction between Arsenic Exposure from Drinking Water and Genetic Polymorphisms on Cardiovascular Disease in Bangladesh: A Prospective Case-Cohort Study

Background: Epidemiologic data on genetic susceptibility to cardiovascular effects of arsenic exposure from drinking water are limited. Objective: We investigated whether the association between well-water arsenic and cardiovascular disease (CVD) differed by 170 single nucleotide polymorphisms (SNPs) in 17 genes related to arsenic metabolism, oxidative stress, inflammation, and endothelial dysfunction. Method: We conducted a prospective case-cohort study nested in the Health Effects of Arsenic Longitudinal Study, with a random subcohort of 1,375 subjects and 447 incident fatal and nonfatal cases of CVD. Well-water arsenic was measured in 2000 at baseline. The CVD cases, 56 of which occurred in the subcohort, included 238 coronary heart disease cases, 165 stroke cases, and 44 deaths due to other CVD identified during follow-up from 2000 to 2012. Results: Of the 170 SNPs tested, multiplicative interactions between well-water arsenic and two SNPs, rs281432 in ICAM1 (padj = 0.0002) and rs3176867 in VCAM1 (padj = 0.035), were significant for CVD after adjustment for multiple testing. Compared with those with GC or CC genotype in rs281432 and lower well-water arsenic, the adjusted hazard ratio (aHR) for CVD was 1.82 (95% CI: 1.31, 2.54) for a 1-SD increase in well-water arsenic combined with the GG genotype, which was greater than expected given aHRs of 1.08 and 0.96 for separate effects of arsenic and the genotype alone, respectively. Similarly, the joint aHR for arsenic and the rs3176867 CC genotype was 1.34 (95% CI: 0.95, 1.87), greater than expected given aHRs for their separate effects of 1.02 and 0.84, respectively. Conclusions: Associations between CVD and arsenic exposure may be modified by genetic variants related to endothelial dysfunction. Citation: Wu F, Jasmine F, Kibriya MG, Liu M, Cheng X, Parvez F, Islam T, Ahmed A, Rakibuz-Zaman M, Jiang J, Roy S, Paul-Brutus R, Slavkovich V, Islam T, Levy D, VanderWeele TJ, Pierce BL, Graziano JH, Ahsan H, Chen Y. 2015. Interaction between arsenic exposure from drinking water and genetic polymorphisms on cardiovascular disease in Bangladesh: a prospective case-cohort study. Environ Health Perspect 123:451–457; http://dx.doi.org/10.1289/ehp.1307883

[1]  C Slot,et al.  Plasma creatinine determination. A new and specific Jaffe reaction method. , 1965, Scandinavian journal of clinical and laboratory investigation.

[2]  S Greenland,et al.  Concepts of interaction. , 1980, American journal of epidemiology.

[3]  K. Aho,et al.  Cerebrovascular disease in the community: results of a WHO collaborative study. , 1980, Bulletin of the World Health Organization.

[4]  C. Chen,et al.  Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. , 1989, American journal of epidemiology.

[5]  S Lemeshow,et al.  Confidence interval estimation of interaction. , 1992, Epidemiology.

[6]  W. Barlow,et al.  Robust variance estimation for the case-cohort design. , 1994, Biometrics.

[7]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[8]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[9]  C. Chen,et al.  Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. , 1997, Stroke.

[10]  V. Gudnason,et al.  C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. , 1997, Atherosclerosis.

[11]  P. Ridker,et al.  Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.

[12]  W E Barlow,et al.  Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.

[13]  S. Blankenberg,et al.  Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease , 2001, Circulation.

[14]  D. Grobbee,et al.  Methylenetetrahydrofolate reductase 677 C/T genotype and cardiovascular disease mortality in postmenopausal women. , 2001, American journal of epidemiology.

[15]  Xing-li Wang,et al.  Glutathione S-Transferase Mu1 Deficiency, Cigarette Smoking and Coronary Artery Disease , 2002, Journal of cardiovascular risk.

[16]  Petra Verhoef,et al.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. , 2002, JAMA.

[17]  Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: Results of a meta-analysis , 2002 .

[18]  L. Vignolo,et al.  Plasma Homocysteine Concentration, C677T MTHFR Genotype, and 844ins68bp CBS Genotype in Young Adults With Spontaneous Cervical Artery Dissection and Atherothrombotic Stroke , 2002, Stroke.

[19]  Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. , 2003 .

[20]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[21]  Amy N. Vidrine,et al.  Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. , 2003, Environmental health perspectives.

[22]  J. Pankow,et al.  Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes. , 2003, Epidemiology.

[23]  Lon R. Cardon,et al.  The complex interplay among factors that influence allelic association , 2004, Nature Reviews Genetics.

[24]  F. Jessen,et al.  Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke , 2004, Neurology.

[25]  Y. Hsueh,et al.  Genetic Polymorphisms of Oxidative and Antioxidant Enzymes and Arsenic-Related Hypertension , 2005, Journal of toxicology and environmental health. Part A.

[26]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[27]  H. Falhammar,et al.  Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[28]  F. Parvez,et al.  Health Effects of Arsenic Longitudinal Study (HEALS): Description of a multidisciplinary epidemiologic investigation , 2006, Journal of Exposure Science and Environmental Epidemiology.

[29]  F. Jasmine,et al.  Arsenic Metabolism, Genetic Susceptibility, and Risk of Premalignant Skin Lesions in Bangladesh , 2007, Cancer Epidemiology Biomarkers & Prevention.

[30]  M. Kibriya,et al.  Association between Arsenic Exposure from Drinking Water and Plasma Levels of Soluble Cell Adhesion Molecules , 2007, Environmental health perspectives.

[31]  J. Hirschhorn,et al.  Genetic model testing and statistical power in population‐based association studies of quantitative traits , 2007, Genetic epidemiology.

[32]  K. Hemminki,et al.  Gene-environment studies: any advantage over environmental studies? , 2007, Carcinogenesis.

[33]  Guey-Shin Wang,et al.  Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.

[34]  M. Bates,et al.  Please Scroll down for Article Journal of Toxicology and Environmental Health, Part A , 2022 .

[35]  H. Chiou,et al.  Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. , 2007, Atherosclerosis.

[36]  L. Cameron,et al.  Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis , 2007, Environmental health : a global access science source.

[37]  H. Chiou,et al.  Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan. , 2008, Toxicology and applied pharmacology.

[38]  Hagit Shatkay,et al.  F-SNP: computationally predicted functional SNPs for disease association studies , 2007, Nucleic Acids Res..

[39]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[40]  L. Le Marchand,et al.  Design Considerations for Genomic Association Studies: Importance of Gene-Environment Interactions , 2008, Cancer Epidemiology Biomarkers & Prevention.

[41]  J. Pankow,et al.  ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA). , 2008, Atherosclerosis.

[42]  Boris Lenhard,et al.  Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3 , 2009, Proceedings of the National Academy of Sciences.

[43]  Thomas Lumley,et al.  Using the whole cohort in the analysis of case-cohort data. , 2009, American journal of epidemiology.

[44]  A. Navas-Acien,et al.  Arsenic in public water supplies and cardiovascular mortality in Spain. , 2010, Environmental Research.

[45]  Kristin E. Porter,et al.  Association of genetic variation in cystathionine-beta-synthase and arsenic metabolism. , 2010, Environmental research.

[46]  S. Tanabe,et al.  Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta, Vietnam. , 2010, Toxicology and applied pharmacology.

[47]  Y. Hsueh,et al.  GT-repeat polymorphism in the heme oxygenase-1 gene promoter and the risk of carotid atherosclerosis related to arsenic exposure , 2010, Journal of Biomedical Science.

[48]  H. Chiou,et al.  Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. , 2011, Environmental research.

[49]  C. Carlson,et al.  Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1). , 2011, Atherosclerosis.

[50]  Mengling Liu,et al.  Association between arsenic exposure from drinking water and proteinuria: results from the Health Effects of Arsenic Longitudinal Study. , 2011, International journal of epidemiology.

[51]  F. Chen,et al.  Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk. , 2011, Carcinogenesis.

[52]  Mengling Liu,et al.  Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study , 2011, BMJ : British Medical Journal.

[53]  M. Vahter,et al.  Polymorphisms in Arsenic(+III Oxidation State) Methyltransferase (AS3MT) Predict Gene Expression of AS3MT as Well as Arsenic Metabolism , 2010, Environmental health perspectives.

[54]  J. Baron,et al.  Genome-Wide Association Study Identifies Chromosome 10q24.32 Variants Associated with Arsenic Metabolism and Toxicity Phenotypes in Bangladesh , 2012, PLoS genetics.

[55]  E. Guallar,et al.  Arsenic Exposure and Cardiovascular Disease:An Updated Systematic Review , 2012, Current Atherosclerosis Reports.

[56]  Fen Wu,et al.  Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers. , 2012, American journal of epidemiology.

[57]  Fen Wu,et al.  A Prospective Study of Arsenic Exposure, Arsenic Methylation Capacity, and Risk of Cardiovascular Disease in Bangladesh , 2013, Environmental health perspectives.

[58]  Abdullah Al Mamun,et al.  Increases in oxidized low-density lipoprotein and other inflammatory and adhesion molecules with a concomitant decrease in high-density lipoprotein in the individuals exposed to arsenic in Bangladesh. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[59]  Nilanjan Chatterjee,et al.  Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. , 2013, Cancer research.

[60]  Tyler R. McClintock,et al.  Arsenic Exposure from Drinking Water and QT-Interval Prolongation: Results from the Health Effects of Arsenic Longitudinal Study , 2013, Environmental health perspectives.

[61]  Fen Wu,et al.  Arsenic exposure from drinking water, arsenic methylation capacity, and carotid intima-media thickness in Bangladesh. , 2013, American journal of epidemiology.

[62]  Ye Tian,et al.  Association between the Polymorphisms in Intercellular Adhesion Molecule-1 and the Risk of Coronary Atherosclerosis: A Case-Controlled Study , 2014, PloS one.

[63]  T. VanderWeele,et al.  Attributing Effects to Interactions , 2014, Epidemiology.

[64]  Fen Wu,et al.  Arsenic Exposure and Subclinical Endpoints of Cardiovascular Disease , 2014, Current Environmental Health Reports.

[65]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[66]  A. Gupta,et al.  Mesa , 2016, Communications of the ACM.